Loading...
Loading...
{
"latency": 227,
"ipAddresses": [
"40.121.8.241"
],
"dns": {
"NS": [
"ns1.markmonitor.com.",
"ns3.markmonitor.com."
],
"A": [
"40.121.8.241"
],
"TXT": [
"padcev.azurewebsites.net",
"39cc7kn5sdbc7hl6m0xnmgjnyxl1h46w"
]
}
}
[
{
"url": "https://padcev.com",
"technologies": [
{
"slug": "windows-server",
"name": "Windows Server",
"icon": "WindowsServer.png",
"versions": [],
"categories": [
{
"id": 28,
"slug": "operating-systems",
"name": "Operating systems"
}
],
"confirmedAt": 1724835517
},
{
"slug": "bootstrap",
"name": "Bootstrap",
"icon": "Bootstrap.svg",
"cpe": "cpe:2.3:a:getbootstrap:bootstrap:*:*:*:*:*:*:*:*",
"versions": [
"4.1.3"
],
"categories": [
{
"id": 66,
"slug": "ui-frameworks",
"name": "UI frameworks"
}
],
"confirmedAt": 1724835517
},
{
"slug": "microsoft-asp-net",
"name": "Microsoft ASP.NET",
"icon": "Microsoft ASP.NET.svg",
"cpe": "cpe:2.3:a:microsoft:asp.net:*:*:*:*:*:*:*:*",
"versions": [
"4.0.30319"
],
"categories": [
{
"id": 18,
"slug": "web-frameworks",
"name": "Web frameworks"
}
],
"confirmedAt": 1724835517
},
{
"slug": "react",
"name": "React",
"icon": "React.svg",
"cpe": "cpe:2.3:a:facebook:react:*:*:*:*:*:*:*:*",
"versions": [],
"categories": [
{
"id": 12,
"slug": "javascript-frameworks",
"name": "JavaScript frameworks"
}
],
"confirmedAt": 1724835517
},
{
"slug": "azure",
"name": "Azure",
"icon": "Azure.svg",
"versions": [],
"categories": [
{
"id": 62,
"slug": "paas",
"name": "PaaS"
}
],
"confirmedAt": 1724835517
},
{
"slug": "iis",
"name": "IIS",
"icon": "Microsoft.svg",
"cpe": "cpe:2.3:a:microsoft:internet_information_server:*:*:*:*:*:*:*:*",
"versions": [
"10.0"
],
"categories": [
{
"id": 22,
"slug": "web-servers",
"name": "Web servers"
}
],
"confirmedAt": 1724835517
},
{
"slug": "cloudflare",
"name": "Cloudflare",
"icon": "CloudFlare.svg",
"versions": [],
"categories": [
{
"id": 31,
"slug": "cdn",
"name": "CDN"
}
],
"confirmedAt": 1724835517
},
{
"slug": "onetrust",
"name": "OneTrust",
"icon": "OneTrust.svg",
"versions": [],
"categories": [
{
"id": 67,
"slug": "cookie-compliance",
"name": "Cookie compliance"
}
],
"confirmedAt": 1724835517
},
{
"slug": "jquery-cdn",
"name": "jQuery CDN",
"icon": "jQuery.svg",
"versions": [],
"categories": [
{
"id": 31,
"slug": "cdn",
"name": "CDN"
}
],
"confirmedAt": 1724835517
},
{
"slug": "google-tag-manager",
"name": "Google Tag Manager",
"icon": "Google Tag Manager.svg",
"versions": [],
"categories": [
{
"id": 42,
"slug": "tag-managers",
"name": "Tag managers"
}
],
"confirmedAt": 1724835517
},
{
"slug": "cdnjs",
"name": "cdnjs",
"icon": "cdnjs.svg",
"versions": [],
"categories": [
{
"id": 31,
"slug": "cdn",
"name": "CDN"
}
],
"confirmedAt": 1724835517
},
{
"slug": "jquery",
"name": "jQuery",
"icon": "jQuery.svg",
"cpe": "cpe:2.3:a:jquery:jquery:*:*:*:*:*:*:*:*",
"versions": [
"3.3.1"
],
"categories": [
{
"id": 59,
"slug": "javascript-libraries",
"name": "JavaScript libraries"
}
],
"confirmedAt": 1724835517
},
{
"slug": "hammer-js",
"name": "Hammer.js",
"icon": "Hammer.js.svg",
"versions": [
"2.0.4"
],
"categories": [
{
"id": 59,
"slug": "javascript-libraries",
"name": "JavaScript libraries"
}
],
"confirmedAt": 1724835517
},
{
"slug": "digicert",
"name": "DigiCert",
"icon": "DigiCert.svg",
"versions": [],
"categories": [
{
"id": 70,
"slug": "ssl-tls-certificate-authorities",
"name": "SSL/TLS certificate authorities"
}
],
"confirmedAt": 1724835517
},
{
"slug": "popper",
"name": "Popper",
"icon": "Popper.svg",
"versions": [
"1.11.0"
],
"categories": [
{
"id": 19,
"slug": "miscellaneous",
"name": "Miscellaneous"
}
],
"confirmedAt": 1724835517
},
{
"slug": "open-graph",
"name": "Open Graph",
"icon": "Open Graph.svg",
"versions": [],
"categories": [
{
"id": 19,
"slug": "miscellaneous",
"name": "Miscellaneous"
}
],
"confirmedAt": 1724835517
}
]
}
]
#updated 02/05/2024
User-agent:*
Sitemap: https://www.padcev.com/sitemap.xml
Sitemap: https://www.padcev.com/image-sitemap.xml
Sitemap: https://www.padcev.com/video-sitemap.xml
# End robots.txt
{
"error": false,
"result": {
"success": true,
"ogTitle": "PADCEV® (enfortumab vedotin-ejfv) | Official Patient Site",
"ogDescription": "Learn more about PADCEV®. Find information on efficacy, dosing, resources, and more. Please see full Prescribing Information, including Serious Side Effects.",
"ogUrl": "https://www.padcev.com/",
"ogType": "website",
"ogSiteName": "PADCEV",
"fbAppId": "249704316580487",
"ogImage": [
{
"url": "https://www.padcev.com/Content/hcp/images/og/Padcev-logo.png",
"type": "png"
},
{
"url": "https://www.padcev.com/Content/hcp/images/og/Padcev-logo.png",
"type": "png"
},
{
"url": "https://www.padcev.com/Content/hcp/images/og/Padcev-logo.png",
"type": "png"
}
],
"ogLocale": "en",
"favicon": "/favicon.ico",
"charset": "UTF-8",
"jsonLD": [
{
"@context": "http://schema.org/",
"@type": "MedicalWebPage",
"specialty": "https://health-lifesci.schema.org/Oncologic",
"audience": "https://health-lifesci.schema.org/Patient",
"url": "https://www.padcev.com/",
"name": "Home",
"headline": "PADCEV® (enfortumab vedotin-ejfv) for Advanced Bladder Cancer",
"description": "PADCEV is used to treat advanced bladder cancer and can be used alone or together with pembrolizumab (also known as Keytruda®). See full Prescribing Information, including Serious Side Effects.",
"potentialAction": [
{
"@type": "ViewAction",
"name": "How PADCEV May Help",
"description": "People who were treated only with PADCEV® demonstrated a median overall survival of 13 months versus 9 months with chemotherapy. This was based on a study of 608 adults with advanced bladder cancer who previously received immunotherapy medicine and cisplatin- or carboplatin-containing chemotherapy.",
"url": "https://www.padcev.com/trial-results"
},
{
"@type": "ViewAction",
"name": "How PADCEV with pembrolizumab may help as a first treatment for advanced bladder cancer",
"description": "PADCEV with pembrolizumab For people who have not yet received a treatment for advanced bladder cancer",
"url": "https://www.padcev.com/trial-results"
},
{
"@type": "ViewAction",
"name": "How PADCEV may help after previous treatment for advanced bladder cancer",
"description": "PADCEV alone For people who have previously received an immunotherapy medicine and chemotherapy that contains platinum (cisplatin or carboplatin) Or For people who are unable to receive cisplatin containing chemotherapy and were previously treated with one or more prior therapies",
"url": "https://www.padcev.com/trial-results"
},
{
"@type": "ViewAction",
"name": "View More Patient Stories",
"url": "https://www.padcev.com/real-patient-stories"
},
{
"@type": "ViewAction",
"name": "PADCEV Support Solutions℠ can help provide you or your loved one with information about financial assistance programs.",
"url": "https://www.padcev.com/padcev-support-solutions"
},
{
"@type": "DownloadAction",
"name": "Download the PADCEV Discussion Guide & Symptom Tracker to help start a conversation with your doctor.",
"url": "https://www.padcev.com/Content/pdf/PADCEV-DDG_Symptom_Tracker.pdf"
},
{
"@type": "ViewAction",
"name": "About Advanced Bladder Cancer",
"url": "https://www.padcev.com/about-advanced-bladder-cancer"
},
{
"@type": "ViewAction",
"name": "Downloads and Links",
"url": "https://www.padcev.com/resources"
},
{
"@type": "ViewAction",
"name": "Frequently Asked Questions",
"url": "https://www.padcev.com/frequently-asked-questions"
}
],
"video": {
"@type": "VideoObject",
"name": "Bodiul's path to PADCEV",
"description": "Bodiul and his oncologist, Dr Putao Cen, talk about his journey with advanced bladder cancer and his experience being treated with PADCEV.",
"thumbnailUrl": "https://www.padcev.com/Content/images/Bodiul-placeholder-v2.png",
"uploadDate": "2022-12-14",
"duration": "PT11M13S",
"embedUrl": "https://app.frame.io/presentations/5dd01843-1d77-44fb-ae93-1cc7537d6ed9"
},
"about": [
{
"@type": "Drug",
"name": "PADCEV",
"alternateName": "enfortumab vedotin-ejfv",
"description": "PADCEV is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. PADCEV may be used with pembrolizumab (also known as Keytruda®), or PADCEV may be used alone if you: have received an immunotherapy medicine and chemotherapy that contains platinum, or are not able to receive a chemotherapy that contains the medicine cisplatin and you have received 1 or more prior therapy. It is not known if PADCEV is safe and effective in children.",
"image": {
"@type": "ImageObject",
"name": "PADCEV (enfortumab vedotin-ejfv) logo",
"contentUrl": "https://www.padcev.com/Content/images/Nav-icons/Padcev-Nav-Logo.svg"
},
"offers": {
"@type": "Offer",
"name": "PADCEV Support Solutions℠",
"description": "PADCEV Support Solutions offers information to help you understand your insurance coverage for PADCEV®. PADCEV Support Solutions will provide your healthcare professional with a summary of your insurance benefits. We can also help determine if your insurer requires a prior authorization (PA). If your insurer denies a PA request, and your healthcare professional determines that an appeal is appropriate, PADCEV Support Solutions can assist with the appeal.",
"price": "0",
"priceCurrency": "USD"
},
"prescribingInfo": "https://astellas.us/docs/PADCEV_label.pdf",
"manufacturer": {
"@type": "Organization",
"name": "Astellas",
"logo": "https://www.padcev.com/Content/images/Astellas_Oncology_Logo.png",
"url": "https://www.astellas.com/us/"
}
},
{
"@type": "MedicalCondition",
"name": [
"bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery"
]
}
]
}
],
"requestUrl": "https://padcev.com"
},
"response": {}
}
{
"status": 200,
"statusText": "",
"headers": {
"cache-control": "private",
"content-encoding": "gzip",
"content-length": "36736",
"content-type": "text/html; charset=utf-8",
"date": "Sat, 01 Feb 2025 01:06:11 GMT",
"server": "Microsoft-IIS/10.0",
"vary": "Accept-Encoding",
"x-aspnet-version": "4.0.30319",
"x-aspnetmvc-version": "5.2",
"x-powered-by": "ASP.NET",
"set-cookie": "ARRAffinitySameSite=896806cac4e5d5e12b304ef679b47b94d6b54029d019793c639b60e7d38471c6;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.padcev.com"
}
}
{
"data": {
"total": 0,
"personal_emails": 0,
"generic_emails": 0,
"department": {
"executive": 0,
"it": 0,
"finance": 0,
"management": 0,
"sales": 0,
"legal": 0,
"support": 0,
"hr": 0,
"marketing": 0,
"communication": 0,
"education": 0,
"design": 0,
"health": 0,
"operations": 0
},
"seniority": {
"junior": 0,
"senior": 0,
"executive": 0
}
},
"meta": {
"params": {
"domain": "padcev.com",
"company": null,
"type": null
}
}
}
{
"Hotjar": "A heatmap, survey, feedback and funnel application.",
"Throtle": "Data onboarding and identity resolution.",
"Google Analytics": "Google Analytics offers a host of compelling features and benefits for everyone from senior executives and advertising and marketing professionals to site owners and content developers.",
"Google Analytics 4": "Google Analytics 4 formerly known as App + Web is a new version of Google Analytics that was released in October 2020.",
"Global Site Tag": "Google's primary tag for Google Measurement/Conversion Tracking, Adwords and DoubleClick.",
"DoubleClick Floodlight": "Floodlight is feature of DoubleClick ads that allows advertisers to capture and report on the actions of users who visit their website after viewing or clicking on one of the advertiser's ads.",
"Google Conversion Linker": "Detects the ad click information in your conversion page URLs and stores this information to associate an ad click with a conversion.",
"Facebook Domain Insights": "This website contains tracking information that allows admins to see Facebook Insights out of Facebook to this domain.",
"Facebook Signal": "Journalists use Signal to surface relevant trends, photos, videos and posts from Facebook and Instagram for use in their storytelling and reporting.",
"Facebook Pixel": "Facebook Pixel is Facebooks conversion tracking system for ads on Facebook to websites.",
"Facebook Conversion Tracking": "Conversion tracking functionality from Facebook, allows a user to track advertisement clicks.",
"OneTrust": "Cookie compliance system.",
"Optanon": "Cookie consent transparency system from OneTrust.",
"Google Tag Manager": "Tag management that lets you add and update website tags without changes to underlying website code.",
"Font Awesome": "Iconic font and CSS toolkit.",
"US Privacy User Signal Mechanism": "The US Privacy API (USP API) is a lightweight API used to communicate signals represented in the US Privacy String.",
"Facebook Data Processing Options": "Give businesses more control over how their data is used in Facebook and support CCPA compliance.",
"CrUX Dataset": "CrUX is a data collection system that gathers information about how real users interact with websites. This website is included in the user experiences data gathered from Google Chrome and thus considered sufficiently popular on the Internet.",
"CrUX Top 5m": "Relative measure of site popularity within the CrUX dataset, measured by the total number of navigations on the origin. This site is in the top 5 million.",
"English HREF LANG": "This webpage has alternate versions available in English via the use of the hreflang tag.",
"English - Inferred": "Based on the title and description text the website content is potentially English.",
"ASP.NET MVC": "Model View Controller Framework for ASP.NET",
"ASP.NET": "ASP.NET is a web application framework marketed by Microsoft that programmers can use to build dynamic web sites, web applications and XML web services. It is part of Microsoft's .NET platform and is the successor to Microsoft's Active Server Pages (ASP) technology.",
"ASP.NET 4.0": "ASP.NET version 4.0.*",
"Materialize CSS": "Material Design CSS Framework",
"MedicalWebPage Schema": "Medical information page.",
"Organization Schema": "Organization i.e. school, NGO, Corporation.",
"MedicalCondition Schema": "A medical condition of the human body.",
"Offer Schema": "Offer to transfer an item or service like tickets, renting or bookings.",
"IPhone / Mobile Compatible": "The website contains code that allows the page to support IPhone / Mobile Content.",
"Viewport Meta": "This page uses the viewport meta tag which means the content may be optimized for mobile content.",
"BootstrapCDN": "Bootstrap CDN system - encompasses MaxCDN, NetDNA and Stackpath - donated to jsDelivr.",
"jQuery CDN": "The jQuery Amazon S3 Content Delivery Network",
"CDN JS": "CloudFlare's CDN with popular javascript frameworks available.",
"Cloudflare JS": "Loads content from Cloudflare CDN.",
"jsDelivr": "A free CDN where Javascript developers can host their files. Encompasses MaxCDN, and BootstrapCDN.",
"Azure Edge": "Content delivered via Azure Edge Network",
"Frame.io": "Video review and collaboration software.",
"VideoJS": "VideoJS is an HTML5 Video Player, built with Javascript and CSS, with a fallback to a Flash video player for when the browser doesn't support HTML5 video. Owned by Brightcove.",
"Bitmovin": "bitmovin is the technology leader in adaptive streaming solutions using MPEG-DASH and HLS.",
"jQuery": "JQuery is a fast, concise, JavaScript Library that simplifies how you traverse HTML documents, handle events, perform animations, and add Ajax interactions to your web pages. jQuery is designed to change the way that you write JavaScript.",
"jQuery 3.3.1": "jQuery version 3.3.1",
"jQuery Waypoints": "Waypoints is a small jQuery plugin that makes it easy to execute a function whenever you scroll to an element.",
"Picturefill": "Responsive image polyfill.",
"pickadate.js": "Mobile-friendly, responsive, and lightweight jQuery date & time input picker.",
"Popper.js": "A library to manage your pop ups.",
"es6 promise": "A polyfill for ES6-style Promises.",
"Facebook SDK": "JavaScript SDK enables you to access all of the features of the Graph API via JavaScript, and it provides a rich set of client-side functionality for authentication and sharing. It differs from Facebook Connect.",
"Facebook for Websites": "Allows a user to make a website more sociable and connected with integrations from the hugely popular Facebook website.",
"Intersection Observer": "API that can be used to understand the visibility and position of DOM elements relative to a containing element or to the top-level viewport.",
"DoubleClick.Net": "DoubleClick enables agencies, marketers and publishers to work together successfully and profit from their digital marketing investments. Owned by Google and now referred to as DoubleClick Digital Marketing or Google Enterprise Advertising.",
"Google Floodlight Counter": "The Floodlight Counter tag allows you to count the number of times someone visits your site after clicking on an advertisement for it.",
"The Trade Desk": "Data-driven marketing suite that offers marketers a single place to buy all forms of online media.",
"The Trade Desk Universal Pixel": "The Trade Desk Universal Pixel is a tracking tag that allows multiple processes to be managed with one pixel added to an entire website. It is a JavaScript (JS) tag that can be used to create conversion tracking tags either through the platform UI or API.",
"Facebook Custom Audiences": "Custom Audiences from your website makes it possible to reach people who visit your website and deliver the right message to them on Facebook.",
"ContextWeb": "ContextWeb, Inc. provides high-precision, real-time contextual advertising solutions guaranteed to maximize the results and impact of online advertising. Now known as PulsePoint.",
"Facebook": "The website mentions facebook.com in some form.",
"Accessibility Statement": "A statement that outlines how a website has been designed to be accessible to people with disabilities.",
"Microsoft": "This site is hosted on Microsoft infrastructure",
"SSL by Default": "The website redirects traffic to an HTTPS/SSL version by default.",
"DigiCert SSL": "Certificate provided by DigiCert.",
"MarkMonitor DNS": "Thomson Reuters owned DNS protection system.",
"IIS": "This website is running on a Microsoft IIS Server solution.",
"IIS 10": "Internet-based services for servers using Microsoft Windows v10.",
"Google Webmaster": "Webmaster tools provide you with a free and easy way to make your site more Google-friendly.",
"Content Delivery Network": "This page contains links that give the impression that some of the site contents are stored on a content delivery network."
}
{
"whois.verisign-grs.com": {
"Domain Status": [
"clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited",
"clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited"
],
"Name Server": [
"NS1.MARKMONITOR.COM",
"NS3.MARKMONITOR.COM"
],
"Domain Name": "PADCEV.COM",
"Registry Domain ID": "2250754720_DOMAIN_COM-VRSN",
"Registrar WHOIS Server": "whois.markmonitor.com",
"Registrar URL": "http://www.markmonitor.com",
"Updated Date": "2021-08-16T04:18:46Z",
"Created Date": "2018-04-11T16:49:29Z",
"Expiry Date": "2025-04-11T16:49:29Z",
"Registrar": "MarkMonitor Inc.",
"Registrar IANA ID": "292",
"Registrar Abuse Contact Email": "[email protected]",
"Registrar Abuse Contact Phone": "+1.2086851750",
"DNSSEC": "unsigned",
"URL of the ICANN Whois Inaccuracy Complaint Form": "https://www.icann.org/wicf/",
">>> Last update of whois database": "2025-02-01T01:06:06Z <<<",
"text": [
"For more information on Whois status codes, please visit https://icann.org/epp",
"",
"NOTICE: The expiration date displayed in this record is the date the",
"registrar's sponsorship of the domain name registration in the registry is",
"currently set to expire. This date does not necessarily reflect the expiration",
"date of the domain name registrant's agreement with the sponsoring",
"registrar. Users may consult the sponsoring registrar's Whois database to",
"view the registrar's reported date of expiration for this registration.",
"",
"TERMS OF USE: You are not authorized to access or query our Whois",
"database through the use of electronic processes that are high-volume and",
"automated except as reasonably necessary to register domain names or",
"modify existing registrations; the Data in VeriSign Global Registry",
"Services' (\"VeriSign\") Whois database is provided by VeriSign for",
"information purposes only, and to assist persons in obtaining information",
"about or related to a domain name registration record. VeriSign does not",
"guarantee its accuracy. By submitting a Whois query, you agree to abide",
"by the following terms of use: You agree that you may use this Data only",
"for lawful purposes and that under no circumstances will you use this Data",
"to: (1) allow, enable, or otherwise support the transmission of mass",
"unsolicited, commercial advertising or solicitations via e-mail, telephone,",
"or facsimile; or (2) enable high volume, automated, electronic processes",
"that apply to VeriSign (or its computer systems). The compilation,",
"repackaging, dissemination or other use of this Data is expressly",
"prohibited without the prior written consent of VeriSign. You agree not to",
"use electronic processes that are automated and high-volume to access or",
"query the Whois database except as reasonably necessary to register",
"domain names or modify existing registrations. VeriSign reserves the right",
"to restrict your access to the Whois database in its sole discretion to ensure",
"operational stability. VeriSign may restrict or terminate your access to the",
"Whois database for failure to abide by these terms of use. VeriSign",
"reserves the right to modify these terms at any time.",
"",
"The Registry database contains ONLY .COM, .NET, .EDU domains and",
"Registrars."
]
},
"whois.markmonitor.com": {
"Domain Status": [
"clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)",
"clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)",
"clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)"
],
"Name Server": [
"ns1.markmonitor.com",
"ns3.markmonitor.com"
],
"Domain Name": "padcev.com",
"Registry Domain ID": "2250754720_DOMAIN_COM-VRSN",
"Registrar WHOIS Server": "whois.markmonitor.com",
"Registrar URL": "http://www.markmonitor.com",
"Updated Date": "2023-08-10T20:07:55+0000",
"Created Date": "2018-04-11T16:49:29+0000",
"Expiry Date": "2025-04-11T16:49:29+0000",
"Registrar": "MarkMonitor, Inc.",
"Registrar IANA ID": "292",
"Registrar Abuse Contact Email": "[email protected]",
"Registrar Abuse Contact Phone": "+1.2086851750",
"Registrant Organization": "Astellas Pharma US, Inc.",
"Registrant State/Province": "Illinois",
"Registrant Country": "US",
"Registrant Email": "Select Request Email Form at https://domains.markmonitor.com/whois/padcev.com",
"Admin Organization": "Astellas Pharma US, Inc.",
"Admin State/Province": "Illinois",
"Admin Country": "US",
"Admin Email": "Select Request Email Form at https://domains.markmonitor.com/whois/padcev.com",
"Tech Organization": "Astellas Pharma US, Inc.",
"Tech State/Province": "Illinois",
"Tech Country": "US",
"Tech Email": "Select Request Email Form at https://domains.markmonitor.com/whois/padcev.com",
"DNSSEC": "unsigned",
"URL of the ICANN WHOIS Data Problem Reporting System": "http://wdprs.internic.net/",
">>> Last update of WHOIS database": "2025-02-01T01:06:12+0000 <<<",
"text": [
"For more information on WHOIS status codes, please visit:",
"https://www.icann.org/resources/pages/epp-status-codes",
"",
"If you wish to contact this domain’s Registrant, Administrative, or Technical",
"contact, and such email address is not visible above, you may do so via our web",
"form, pursuant to ICANN’s Temporary Specification. To verify that you are not a",
"robot, please enter your email address to receive a link to a page that",
"facilitates email communication with the relevant contact(s).",
"",
"Web-based WHOIS:",
"https://domains.markmonitor.com/whois",
"",
"If you have a legitimate interest in viewing the non-public WHOIS details, send",
"your request and the reasons for your request to [email protected]",
"and specify the domain name in the subject line. We will review that request and",
"may ask for supporting documentation and explanation.",
"",
"The data in MarkMonitor’s WHOIS database is provided for information purposes,",
"and to assist persons in obtaining information about or related to a domain",
"name’s registration record. While MarkMonitor believes the data to be accurate,",
"the data is provided \"as is\" with no guarantee or warranties regarding its",
"accuracy.",
"",
"By submitting a WHOIS query, you agree that you will use this data only for",
"lawful purposes and that, under no circumstances will you use this data to:",
"(1) allow, enable, or otherwise support the transmission by email, telephone,",
"or facsimile of mass, unsolicited, commercial advertising, or spam; or",
"(2) enable high volume, automated, or electronic processes that send queries,",
"data, or email to MarkMonitor (or its systems) or the domain name contacts (or",
"its systems).",
"",
"MarkMonitor reserves the right to modify these terms at any time.",
"",
"By submitting this query, you agree to abide by this policy.",
"",
"MarkMonitor Domain Management(TM)",
"Protecting companies and consumers in a digital world.",
"",
"Visit MarkMonitor at https://www.markmonitor.com",
"Contact us at +1.8007459229",
"In Europe, at +44.02032062220"
]
}
}